Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Income from Continuing Operations (2022 - 2026)

Core Laboratories filings provide 5 years of Income from Continuing Operations readings, the most recent being 704000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 1120.29% to 704000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 29583000.0, a 2.84% increase, with the full-year FY2025 number at 30391000.0, down 5.48% from a year prior.
  • Income from Continuing Operations hit 704000.0 in Q1 2026 for Core Laboratories, down from 5129000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 22970000.0 in Q2 2023 to a low of 704000.0 in Q1 2026.
  • Median Income from Continuing Operations over the past 5 years was 7333500.0 (2022), compared with a mean of 7484250.0.
  • Biggest five-year swings in Income from Continuing Operations: surged 220.99% in 2023 and later tumbled 1120.29% in 2026.
  • Core Laboratories' Income from Continuing Operations stood at 5984000.0 in 2022, then tumbled by 59.32% to 2434000.0 in 2023, then skyrocketed by 208.59% to 7511000.0 in 2024, then plummeted by 31.71% to 5129000.0 in 2025, then tumbled by 113.73% to 704000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 704000.0 (Q1 2026), 5129000.0 (Q4 2025), and 14478000.0 (Q3 2025) per Business Quant data.